BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  OncoMed Announces Chairman, President and Chief Executive Officer Paul J. Hastings to Resume Chairman Responsibilities

  Office of the President continues to perform the duties of President and CEO.

  November 28, 2017

   · 

  3 min read
• Biotech Bay

  Varian Medical Schedules Annual Stockholder Meeting in Palo Alto

  Varian Medical Systems announced today that its Board of Directors has scheduled the 2018 Annual Meeting of Stockholders for February 8, 2018 with a record date of December 11, 2017.

  November 28, 2017

   · 

  1 min read
• Business

  SynDaver Creates Global Business Unit, Names VP of Global Government Business Development

  SynDaver recently announced the creation of the new Global Government Business Unit.

  November 28, 2017

   · 

  3 min read
• Biotech Beach

  VascuStim Announces Launch of Diabetic Ulcer Clinical Research Program

  VascuStim an emerging leader in advanced bioelectric innovations and technologies for peripheral vascular diseases, today announced the launch of a clinical research program which will comprise multiple studies and an international patient registry.

  November 28, 2017

   · 

  5 min read
• BioMidwest

  Fagron Announces Stability Data on LETS GEL KIT for Rapid Topical Anesthesia

  Fagron announces 90 day beyond-use-dating study results for their industry leading LETS GEL KIT.

  November 28, 2017

   · 

  2 min read
• A*STAR’s Genome Institute of Singapore (GIS) :A Step Forward in Mending Damaged Lungs Using Stem Cells

  New research has discovered a means to partially repair damaged lungs.

  November 28, 2017

   · 

  6 min read
• CollPlant Receives Substantial, Repeat Order for its Biological Ink

  CollPlant announced that it has received an additional order, totaling hundreds of thousands of dollars, for the supply of its collagen and biological ink.

  November 28, 2017

   · 

  2 min read
• BioMidwest

  Turner Imaging Systems Announces Closing of Seed Investment Round

  The round was led by venture capital firm Cavendish Impact Capital with participation from other private investors.

  November 28, 2017

   · 

  2 min read
• Drug Development

  Cidara Therapeutics Completes Enrollment in Phase II STRIVE Trial Evaluating Novel Antifungal Rezafungin (CD101 IV) in Invasive Fungal Infections

  Cidara expects to report topline data for STRIVE in the first quarter of 2018, and begin Phase 3 trials for the treatment and prophylaxis of invasive fungal infections in mid-2018.

  November 28, 2017

   · 

  4 min read
• 

  Policy

  CytomX Therapeutics Announces FDA Acceptance of Investigational New Drug Application for CTLA-4 Probody Therapeutic

  The IND acceptance results in a $10 million milestone payment to CytomX.

  November 28, 2017

   · 

  4 min read